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연구 배경 : Adenosine deaminase (ADA)는 퓨린 (purine) 대사에 작용하는 효소로서 림프구, 특히 T-림프구의 증식과 
분화에 관여하며, 결핵성 흉수의 진단에 있어서 중요한 생화학적 표지자 중의 하나이다. 한편, 노인의 경우, T-림프구의 
수와 기능의 감소에 의하여 면역 기능이 감소하는 것으로 알려져 있다. 이에 저자 등은 노인 결핵성 흉수 환자에서 흉수 
내의 ADA 수치가 젊은 환자에서보다 감소하는지를 조사하였다. 
방  법 : 4년 동안 세브란스 병원에서 1) 흉수 결핵균 배양 양성 또는 2) 흉막 조직 검사상 결핵에 합당한 소견을 보여 
결핵성 흉수로 진단받은 환자 80명을 대상으로 후향적으로 조사하였다. 65세를 기준으로 두 군으로 분류하였으며, 연령
과 흉수 ADA 수치의 연관 관계를 독립 표본 t-검정 및 선형 회귀 분석을 이용하여 연구하였다.
결  과 : 80명의 환자 중 65세 이상은 21명 (26.3%)이었다. 흉수 내의 ADA 수치는 65세 이상 및 이하 군에서 각각 71.2 
± 27.6 IU/L, 68.5 ± 25.8 IU/L 이었다 (p=0.69). 선형 회귀 분석에서도 연령과 흉수 내의 ADA 수치는 상관 관계를 보이
지 않았다 (r²=0.05, p=0.59). 
결  론 : 본 연구의 결과에 의하면, 결핵성 흉수의 진단에서 흉수 ADA 수치를 보조 지표로 사용하는 데 있어서, 노인 
환자에서도 젊은 환자와 동일한 임상적 유의성을 가지고 동일한 결정 수치 (cut-off value)를 적용할 수 있을 것으로 판단
된다.  (Tuberc Respir Dis 2005; 58: 459-464)
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INTRODUCTION
For most cases of tuberculous pleural effusion, 
the number of the organisms in the pleural effusion 
is very small, so the conventional methods for the 
detection of M. tuberculosis are often of no use. The 
culture is positive in less than 25% of cases1 and 
even the pleural biopsy shows granulomatous 
inflammation only in approximately 60% of cases2,3. 
Even though the combination of the microscopic ex󰠀
amination and the culture of pleural biopsy specimens 
was reported to increase the diagnostic rate up to 
90%4, it is time-consuming. The diagnosis of the 
cases with tuberculosis at an earlier stage would be 
advantageous because they are less contagious5,6 
and have lower morbidity and mortality7. The early 
diagnosis of pleural tuberculosis has been greatly 
improved by the use of the biochemical markers 
such as adenosine deaminase (ADA), interferon-γ, 
and lysozyme2,8-10. Among them, the determination 
of the ADA level in pleural fluid appears to be the 
most promising for the diagnosis of pleural tuber󰠀
culosis because of its ease, rapidity, and cost-effe󰠀
ctiveness. ADA is found in most cells, but its major 
role is concerned with the proliferation and differentiation 
of lymphocytes, especially T-lymphocytes. For this 
reason, ADA has been thought of as a marker of the 
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cell-mediated immunity including the delayed hyper󰠀
sensitivity reaction which is the key mechanism of 
tuberculous pleural effusion. 
Immunosenescence, the progressive decline in the 
immune function that develops with aging, has 
largely been attributed to the alterations in the 
T-cell immunity11-14. The loss of the effective 
immune activity within the T-cell compartment is 
partly caused by the thymic involution15. Substantial 
changes in both the number and the function of 
T-cells have been reported with an advancing age16,17. 
For the number of T-cells, one of the most consistent 
changes with an advancing age, is a decrease in the 
proportion of naive T-cells with a concomitant increase 
in the proportion of activated/memory T-cells. The 
observed functional changes include decreased res󰠀
ponses to T-cell receptor stimulations, impaired T-cell 
proliferative capacities, decreased number of interleukin- 
2-producing CD4+ T-cells, and decreased interleukin-2 
receptor expressions. These latter findings probably 
explain the loss of the proliferative capabilities of 
T-cells from the aged individuals18.
In this study, we hypothesized that the pleural 
fluid ADA activity might be lower in the elderly 
patients and investigated whether we should apply 
a different cut-off value to them for the diagnosis of 
pleural tuberculosis.
METHODS
Study Population and Samples
We retrospectively reviewed the patients older 
than 18 years who were diagnosed with tuberculous 
pleural effusion at the Severance Hospital, over a 
4-year period (June 2000 – June 2004). The diagnostic 
criteria used were as follows: positive M. tuberculosis 
culture of pleural effusion, and/or histopathologic finding 
consistent with tuberculosis on pleural biopsy. Among 
them, the immunocompromised patients due to the 
underlying diseases such as diabetes mellitus, liver 
cirrhosis, uremia, malnutrition, leukemia, and lymphoma, 
were excluded. The patients taking immunosuppressive 
medications such as corticosteroid, cyclosporine, 
cyclophosphamide, azathioprine, and mycophenolic 
acid, were also excluded. 
We reviewed the pleural effusion ADA level, the 
differential cell count from pleural effusion and peri󰠀
pheral blood, the pleural effusion lactate dehydrogenase 
(LDH) level, and the pleural effusion/serum LDH 
ratio. 
AFB Smear and Culture of Mycobacterium 
tuberculosis
The Ziehl-Neelsen staining and the 3% Ogawa 
medium culture were performed with the pleural 
effusion specimens and the sputa.
Determination of Adenosine Deaminase (ADA) 
Activity in Pleural Effusion
The ADA activity was determined by the colorime󰠀
tric method described by Giusti19. The ADA level 
below 45 IU/L was considered as negative in this 
study20,21.  
Statistical Analysis  
The pleural effusion ADA activity, pleural effusion 
LDH level, pleural effusion/serum LDH ratio, pleural 
effusion leukocyte and lymphocyte count, peripheral 
blood leukocyte and lymphocyte count from the 
patients older than 65 years were compared with 
those from the younger patients by student’s t-test. 
The sensitivity of the pleural effusion ADA activity 
was compared between the two age groups by Fisher’s 
exact test. The relationship between age, pleural 
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Table 1. Clinical characteristics of the patients 
＞ 65 years old
(n=21)
≤ 65 years old 
(n=59) p-value
No. of females (%) 4 (19.0%) 18 (30.5%) 0.40‡
No. of cases with positive PE MTB culture (%) 7 (33.3%) 23 (39.0%) 0.79‡
No. of cases with positive pleural pathology (%) 16/19*(84.2%) 46/53†(86.8%) 0.72§
No. of cases with ADA >45 IU/L (%) 18 (85.7%) 50 (84.7%) 1.00§
PE LDH (IU/L) (mean±SD) 1008 ± 542 1020 ± 552 0.93ll
PE/Serum LDH ratio 2.29 ± 1.50 2.54 ± 1.58 0.56ll
LDH: lactate dehydrogenase, MTB: Mycobacterium tuberculosis, PE: pleural effusion
*16 of the 19 biopsy-performed patients showed the histopathologic findings consistent with pleural tuberculosis.
†46 of the 53 biopsy-performed patients showed the histopathologic findings consistent with pleural tuberculosis.
‡Pearson's chi-square test was used.
§Fisher's exact test was used.
llStudent's t-test was used.
effusion lymphocyte count, and pleural fluid ADA 
activity was examined using multiple linear regression 
analysis. The differences were considered statistically 
significant if p-value was less than 0.05.
RESULTS
Subjects’ Characteristics
A total of 80 patients were included, who con󰠀
sisted of 22 females and 58 males. The patients’ age 
ranged from 19 to 85 years. The pleural effusion M. 
tuberculosis culture was positive in 30 (37.5%) cases. 
Pleural biopsy was not performed in 8 (10.0%) 
patients due to a small amount of pleural effusion. 
Out of the 72 biopsy-performed cases, 62 (86.1%) 
showed the pleural histopathology consistent with 
tuberculosis. The pleural effusion ADA activity was 
between 10.4 and 133.0 IU/L. 
The subjects included 21 patients older than 65 
years and 59 patients younger than 65 years. The 
female patients were 4 (19.0%) of 21 and 18 (30.5%) 
of 59 in each group (p >0.05). The pleural effusion 
M. tuberculosis culture was positive in 7 (33.3%) of 
21 and in 23 (39.0%) of 59 patients, respectively (p 
>0.05). Pleural biopsy was performed to 19 (90.5%) 
of 21 and to 53 (89.8%) of 59 patients in each group. 
The pleural biopsy pathology was consistent with 
tuberculosis in 16 (84.2%) of 19 and in 46 (86.8) of 
53 biopsy-performed patients, respectively (p >0.05). 
The pleural effusion ADA level was above 45 IU/L 
in 18 (85.7%) of 21 and in 50 (84.7%) of 59 patients 
(p >0.05). The lactate dehydrogenase (LDH) level in 
the pleural effusion specimen was 1008±542 IU/L 
and 1020±552 IU/L, respectively. The pleural fluid to 
serum LDH ratio was 2.29±1.50 and 2.54±1.58 in 
each group (p >0.05) (Table 1). 
Comparison of Pleural Effusion ADA Activity, 
Pleural Effusion Leukocyte and Lymphocyte Co󰠀
unt, Peripheral Blood Leukocyte and Lymphocyte 
Count between Two Age Groups  
The pleural effusion ADA level was 71.2±27.6 
IU/L in the elderly group and 68.5±25.8 IU/L in the 
younger group (p=0.69). The pleural effusion leukocyte 
count was 1189±1892/μL and 2014±2158/μL, respect󰠀
ively (p=0.19). The pleural effusion lymphocyte count 
was 932±1500/μL and 1777±1568/μL in each group. 
It was slightly lower in the elderly group even 
though the result was not statistically significant 
(p=0.07). The peripheral blood leukocyte count was 
7543±3180/μL and 6898±2215/μL, respectively (p=0.31). 
The peripheral blood lymphocyte count was 844± 
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Figure 1. Relationship between pleural effusion ADA 
activity and age in the patients with tuberculous 
pleural effusion.
Multiple linear regression analysis did not show a 
significant correlation between age and pleural fluid 
ADA activity (r2=0.05, p=0.59).
Table 2. Comparison of ADA activity and cell counts between two groups*
＞ 65 years old
(n=21)
≤ 65 years old 
(n=59) p-value
Pleural effusion ADA level (IU/L) 71.2 ± 27.6 68.5 ± 25.8 0.69† 
Pleural effusion WBC count (/μL) 1189 ± 1892 2014 ± 2158 0.19† 
Pleural effusion lymphocyte count (/μL) 932 ± 1500 1777 ± 1568 0.07† 
Peripheral blood WBC count (/μL) 7543 ± 3180 6898 ± 2215 0.31† 
Peripheral blood lymphocyte count (/μL) 844 ± 527 1251 ± 424 0.001† 
*The values are expressed as mean ± standard deviation. 
†Student's t-test was used.
527/μL in the elderly group and 1251±424/μL in the 
younger group (p=0.001) (Table 2). The multiple linear 
regression analysis of the relationship between age, 
pleural effusion lymphocyte count, and pleural fluid 
ADA activity did not show a significant correlation, 
either (r2=0.05, p=0.59) (Fig. 1).
DISCUSSION 
ADA catalyzes the conversion of adenosine and 
deoxyadenosine to inosine and deoxyinosine, res󰠀
pectively22. Because ADA is primarily concerned with 
the proliferation and differentiation of T-lymphocytes23, 
the pleural effusion ADA activity is thought to re󰠀
flect the cellularity of activated T-lymphocytes in 
the pleural compartment. According to some previous 
reports, the serum ADA level was lower in the 
patients with severe combined immunodeficiency24, 
and it was higher in the patients with increased 
cell-mediated immunity due to typhoid fever, infectious 
mononucleosis, viral hepatitis, chronic liver disease, 
etc. According to Hsu et al., the diagnostic value of 
ADA in the immunocompromised hosts with tuberculous 
pleural effusion was not as significant as in the im󰠀
munocompetent hosts25. On the contrary, Riantawan 
et al. showed that the diagnostic value of the pleural 
effusion ADA activity was not different between the 
human immunodeficiency virus (HIV)-seropositive 
and the HIV-seronegative patients26.   
We partitioned the patients into two groups, one 
older than 65 years and the other younger. The 
results indicated that the pleural effusion ADA level 
did not correlate with the patient’s age. The mean 
value and the sensitivity of the pleural effusion 
ADA level did not show statistically significant 
differences between the two age groups. The pleural 
effusion lymphocyte count was slightly lower in the 
elderly patients even though not statistically sign󰠀
ificant, and the peripheral blood lymphocyte count 
was much lower in the elderly patients with a 
statistical significance. This might suggest that the 
activated lymphocyte count in the pleural effusion is 
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similar between the two age groups in spite of the 
difference in the total lymphocyte count. In the future, 
therefore, it would be necessary to compare the 
activated lymphocyte counts between the two age 
groups, possibly by means of the stimulation of the 
lymphocytes with the mycobacterial antigens such 
as culture filtrate proteins and purified protein 
derivatives. 
From these results, we can assume that it is 
reasonable to apply the same cut-off value of the 
pleural fluid ADA level with the same clinical sign󰠀
ificance, to both the elderly and the younger patients, 
for the diagnosis of pleural tuberculosis. Our results 
were in some accordance with Riantawan et al.’s 
study which showed that the pleural effusion ADA 
level of the HIV-seropositive patients did not differ 
from that of the HIV-seronegative ones26.
In this study, we included only the cases of 
confirmed tuberculous pleural effusion with positive 
M. tuberculosis culture of pleural effusion and/or 
histopathologic finding consistent with tuberculosis 
on pleural biopsy. We excluded the patients with 
probable pleural tuberculosis who had one of the 
following: positive M. tuberculosis culture of biologic 
specimens other than pleural effusion, and/or positive 
response to anti-tuberculous medications without 
other possible causes of pleural effusion. And hence 
the M. tuberculosis culture-positive and the pleural 
pathology-positive rate were higher than those in 
the previous studies in which the cases with pro󰠀
bable pleural tuberculosis were also enrolled.
A lot of Korean elderly people are thought to have 
been exposed to M. tuberculosis in their early lives 
and are suspected to be in the state of latent 
infection. This might have induced the activation of 
the memory T-lymphocytes when developing pleural 
tuberculosis in the elderly group. Even though the 
number of the naïve T-lymphocytes was decreased 
in the elderly, these memory T-lymphocytes might 
have proliferated and released ADA in the pleural 
space, to the same degree as in the younger patients. 
In conclusion, it is assumed that we can apply the 
same cut-off value of the pleural effusion ADA 
activity with the same clinical significance, to both 
the elderly and the younger patients, for the dia󰠀
gnosis of pleural tuberculosis. Considering the 
limitations of a retrospective study, further prospective 
studies including much more cases will be necessary 
in the future.
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